| Abstrakt: |
A researcher at Chongqing Medical University in China has published a study on the detection of serum CC16, a potential biomarker for lung injury diseases. The study developed a magnetic nanoparticles chemiluminescence immunoassay (MNPs-CLIA) for the automated detection of CC16 in serum samples. The MNPs-CLIA method showed consistent results with the currently used ELISA method and demonstrated diagnostic efficacy for silicosis, chronic obstructive pulmonary disease (COPD), and pulmonary sarcoidosis. The researchers concluded that the MNPs-CLIA method has the advantages of automation, high throughput, rapidity, and simplicity, making it suitable for clinical applications in predicting and diagnosing lung diseases. [Extracted from the article] |
